kr174.30
3.50%
Stockholm, Sep 25, 05:29 pm CEST. Closed.
ISIN
SE0000135485
Symbol
RAY B

RaySearch Laboratories Target price 2026 - Analyst rating & recommendation

RaySearch Laboratories Classifications & Recommendation

Buy
89%
Hold
11%

RaySearch Laboratories Price Target

Target Price kr311.10
Price kr174.30
Potential
Number of Estimates 5
5 Analysts have issued a price target RaySearch Laboratories 2027 . The average RaySearch Laboratories target price is kr311.10. This is higher than the current stock price. The highest price target is
kr378.00 116.87%
register free of charge
, the lowest is .
A rating was issued by 9 analysts: 8 Analysts recommend RaySearch Laboratories to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the RaySearch Laboratories stock has an average upside potential 2027 of . Most analysts recommend the RaySearch Laboratories stock at Purchase.

Sales and Margin forecast 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Billion kr 1.34 1.44
12.77% 6.97%
EBITDA Margin 40.88% 45.81%
6.23% 12.07%
Net Margin 16.95% 19.25%
0.74% 13.60%

5 Analysts have issued a sales forecast RaySearch Laboratories 2026 . The average RaySearch Laboratories sales estimate is

kr1.4b
unlock
. This is
13.20% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
kr1.5b 16.74%
unlock
, the lowest is
kr1.4b 6.51%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 kr1.3b 12.77%
2026
kr1.4b 6.97%
unlock
2027
kr1.7b 16.83%
unlock
2028
kr1.9b 13.27%
unlock

5 Analysts have issued an RaySearch Laboratories EBITDA forecast 2026. The average RaySearch Laboratories EBITDA estimate is

kr659m
unlock
. This is
43.66% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
kr679m 48.17%
unlock
, the lowest is
kr619m 35.08%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 kr550m 5.74%
2026
kr659m 19.87%
unlock
2027
kr767m 16.42%
unlock
2028
kr890m 16.12%
unlock

EBITDA Margin

2025 40.88% 6.23%
2026
45.81% 12.07%
unlock
2027
45.65% 0.35%
unlock
2028
46.79% 2.50%
unlock

5 RaySearch Laboratories Analysts have issued a net profit forecast 2026. The average RaySearch Laboratories net profit estimate is

kr277m
unlock
. This is
29.98% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
kr282m 32.59%
unlock
, the lowest is
kr263m 23.59%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 kr228m 11.94%
2026
kr277m 21.54%
unlock
2027
kr345m 24.70%
unlock
2028
kr406m 17.65%
unlock

Net Margin

2025 16.95% 0.74%
2026
19.25% 13.60%
unlock
2027
20.55% 6.75%
unlock
2028
21.34% 3.84%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share kr 6.64 8.23
11.78% 23.95%
P/E 21.17
EV/Sales 4.12

5 Analysts have issued a RaySearch Laboratories forecast for earnings per share. The average RaySearch Laboratories EPS is

kr8.23
unlock
. This is
32.32% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
kr8.40 35.05%
unlock
, the lowest is
kr7.83 25.88%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 kr6.64 11.78%
2026
kr8.23 23.95%
unlock
2027
kr10.27 24.79%
unlock
2028
kr12.08 17.62%
unlock

P/E ratio

Current 28.02 40.47%
2026
21.17 24.45%
unlock
2027
16.97 19.84%
unlock
2028
14.43 14.97%
unlock

Based on analysts' sales estimates for 2026, the RaySearch Laboratories stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 4.66 35.37%
2026
4.12 11.67%
unlock
2027
3.52 14.41%
unlock
2028
3.11 11.72%
unlock

P/S ratio

Current 4.54 36.74%
2026
4.01 11.66%
unlock
2027
3.44 14.41%
unlock
2028
3.03 11.72%
unlock

Current RaySearch Laboratories Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
DNB CARNEGIE
Locked
➜
Locked
Locked Aug 13 2026
DNB CARNEGIE
Locked
➜
Locked
Locked Jul 07 2026
DNB CARNEGIE
Locked
➜
Locked
Locked Jul 06 2026
DNB CARNEGIE
Locked
➜
Locked
Locked Feb 13 2026
Analyst Rating Date
Locked
DNB CARNEGIE:
Locked
➜
Locked
Aug 13 2026
Locked
DNB CARNEGIE:
Locked
➜
Locked
Jul 07 2026
Locked
DNB CARNEGIE:
Locked
➜
Locked
Jul 06 2026
Locked
DNB CARNEGIE:
Locked
➜
Locked
Feb 13 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today